Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The collaboration offers opportunities for training, research fellowships, workshops and conferences at palliative care centers managed by Ajit Isaac Foundation
Gross Profit stood at Rs. 36.02 crore compared to Rs. 20.42 crore during Q2FY24, a significant increase of 76.40%
Hospital business revenues increase 13.9% to Rs. 1,655 crore
Tyvek with Renewable Attribution is designed to help reduce the carbon footprint
Max Healthcare Institute has reported total income of Rs. 1,748.30 crores during the period ended September 30, 2024
Subscribe To Our Newsletter & Stay Updated